Notal Vision Monitoring Center

03/12/2026

Advanced at-home monitoring is becoming an important part of the conversation.

In a recent patient-education article, the American Academy of Ophthalmology highlights the role of at-home monitoring for people living with AMD. Home-based technologies can help extend care beyond the clinic. SCANLY Home OCT and ForeseeHome enable remote disease monitoring between scheduled visits for appropriate patients with AMD.

As monitoring technologies continue to advance, conversations like this help patients better understand how care can extend beyond the clinic visit.

Read the article 👉 https://notalvision.info/4bjpEcH

An FDA-approved at-home monitoring program for wet AMD may help make care easier and more personalized. Special devices let patients use OCT to check their eyes at home.

03/04/2026

Congratulations to Dr. Katia Taba and the Retina Group of Florida team for catching a patient’s wet conversion with ForeseeHome.

In this case, the patient was referred with 20/30 vision and generated a ForeseeHome alert just over a month later, leading to a wet AMD diagnosis at 20/50. Without home monitoring, the patient may not have been evaluated again until their next regularly scheduled appointment months later.

Timely evaluation and treatment initiation are widely recognized as important factors in visual outcomes for wet AMD. ForeseeHome monitoring between exams can help bring potential changes to clinical attention sooner.

The Notal Vision Monitoring Center is proud to partner with Retina Group of Florida to support ongoing AMD monitoring between visits.

02/27/2026

Are you at ? Make sure to stop by booth #246, say hi to Kenny, and learn more about how our remote monitoring solution can help your AMD patients maintain their good vision.

02/26/2026

Live from the 2026 meeting in San Diego.

Prof. Anat Loewenstein presented new data evaluating longitudinal Home OCT trajectories in neovascular AMD using the AI-based Notal OCT Analyzer (NOA).

The takeaway: AI-based trajectory analysis can accurately distinguish stable from changing patterns in Home OCT data, and personalized thresholds may enhance sensitivity in identifying change over time.

Congratulations to current president Julia Haller, MD and the organizing team for an excellent meeting that continues to spotlight the research shaping the future of retinal care.

02/25/2026

After over 5 years of monitoring with the ForeseeHome AMD Monitoring Program, this patient experienced a timely detection of wet in the left eye - caught at 20/50+2 vision - thanks to Dr. Melissa Summerfield and the North Iowa Eye Clinic team in Mason City, Iowa.

Early detection makes the difference in AMD management!

02/18/2026

After just 9 months of consistent monitoring with ForeseeHome, this patient’s progression to wet was detected early—while vision was still 20/25 – thanks to Joseph Anderson, OD, and team at Clarkson Eyecare in Lilburn, GA.

ForeseeHome serves as a vital safety net for AMD patients, helping detect early changes between office visits.

02/12/2026

What happens when AI meets longitudinal, at-home retinal imaging?

In a recent Retina Synthesis conversation, Dr. Carmen Puliafito and Dr. Ted Leng discussed research evaluating AI analysis of daily Home OCT imaging in neovascular AMD. The study showed strong agreement between AI outputs and expert human graders and highlighted the potential value of personalized change thresholds when assessing disease activity over time.

As retinal care continues to evolve, the integration of remote imaging, physician oversight, and AI-driven analysis may help clinicians stay more closely connected to what’s happening between regularly scheduled clinic assessments, while keeping treatment decisions firmly grounded in in-office evaluation.

Watch/listen to the full discussion:

We discuss a study that showed that an artificial intelligence powered system can detect clinically significant fluid as well as experienced observers using ...

02/11/2026

After over 7 years of nearly daily monitoring with ForeseeHome, a patient of Thomas Robertson, MD at Rocky Mount Eye in Rocky Mount, North Carolina experienced a timely detection of wet AMD at 20/25 vision.

The patient previously received a non-exudative alert just 2 months earlier. These types of early alerts are clinically significant as a sub-analysis of the ALOFT study shows they can predict increased risk of wet AMD conversion, underscoring the importance of close monitoring.

Read the analysis here: https://notalvision.info/3ZvEibn

02/10/2026

A growing wave of vision-threatening eye disease is approaching and meeting it will require more than new treatments alone.

Protecting sight at scale means rethinking how care happens between visits, where disease progression can occur silently and opportunities for timely clinical awareness may be missed.

Remote monitoring, AI-supported image analysis, and dedicated monitoring infrastructure are beginning to reshape what continuous eye care can look like; helping physicians stay informed while keeping patients connected to care.

The cruel irony is that incredibly effective treatments already exist. Many people, however, cannot access them due to barriers to care

02/05/2026

A new editorial in Ophthalmology Science discusses the role of Home OCT imaging in Protocol AO, conducted through the DRCR Retina Network, and how frequent imaging may help inform monitoring thresholds and advance research in neovascular AMD.

As clinical understanding evolves, high-frequency retinal imaging continues to shape important scientific dialogue around disease activity between clinic visits.

Read more:
https://notalvision.info/4by9HkJ

02/04/2026

Congratulations to Dr. Tony Tsai and the Retinal Consultants - RetinalMD.com team on another ForeseeHome catch case.

In this case, a patient referred with 20/25 vision generated a ForeseeHome alert more than two years later, with wet AMD subsequently diagnosed at 20/50.

This is a great example of how ongoing home monitoring can provide meaningful insight outside of routine appointment schedules—especially for patients with limited access to in-person care.

The Notal Vision Monitoring Center is proud to partner with Retinal Consultants Medical Group to support proactive AMD monitoring and timely clinical awareness.

02/03/2026

Worth a read from Joshua Mali, MD on what’s ahead for ophthalmology in 2026.

Appreciate the inclusion of AI-enabled home OCT, including SCANLY Home OCT, as part of the broader conversation around how care may continue to evolve between visits.

Many thanks, Dr. Mali, for sharing your perspective.

From artificial intelligence and IOL innovation to biosimilars, geographic atrophy, and postoperative eye protection, Joshua Mali, MD, FASRS, shares what he believes will define ophthalmology in the year ahead.